GoAI
Get started
Toho Holdings Co., Ltd. logo

Toho Holdings Co., Ltd.

8129.T

JPXHealthcareMedical - Distribution

Open in GoAI

Latest quote

¥3,962

−¥38.00 · -0.95%

Aug 24, 2:39 PM JST

8129.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Toho Holdings Co., Ltd. serves as a leading wholesaler of pharmaceutical and healthcare products throughout Japan. Its extensive product range includes prescription and over-the-counter medications, reagents, medical devices and supplies, and health foods, in addition to offerings for preventive, clinical, community, and home-based medical and nursing care. Beyond distribution, the company provides comprehensive support services like developing and selling customer-focused software, assisting with the establishment of new medical facilities and pharmacies, delivering management consulting, offering medical assistance, and facilitating personnel recruitment. Toho Holdings also operates dispensing pharmacies, manufactures and distributes generic drugs, acts as a site management organization (SMO) to support clinical trials for various healthcare institutions, and supplies specialized software to the medical sector. Among its technological solutions are customer support systems such as ENIF for pharmaceutical ordering, ENI-Pharmacy for streamlining dispensing and prescribing processes, LXMATE HeLios for medical appointments, KAITOS for online medical consultations and medication guidance, ENIFwin for inventory control in large hospitals, the ENIFvoice series for voice-activated electronic medication history recording, and ENIF Nurse for home-visit nurse operational support, along with diverse logistics systems. The company, founded in 1948, is headquartered in Tokyo, Japan.

Industry
Medical - Distribution
Sector
Healthcare
Headquarters
JP
CEO
Hiromi Edahiro
Listed since
Dec 11, 2002
Employees
7,675

Market position

Day range

Current ¥3,962

52-week range

Current ¥3,962

Open
¥4,030
Previous close
¥4,000
Volume
56.5K
0.39× average
Average volume
143.8K
Average daily volume
Market cap
256.35B JPY
Beta
-0.08
Market reference 1
50-day average
¥3,944.84
+0.43% above average
200-day average
¥4,438.4
-10.73% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM)
15.68×
P/B (TTM)
0.97×
P/S (TTM)
0.16×
Dividend yield
4.16%

Profitability & efficiency

Gross margin
7.37%
Operating margin
0.99%
Net margin
1.04%

Financial health

Debt / equity
0.02×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends9%6%3%0%Gross margin, FY2021: 8.08%Gross margin, FY2022: 7.54%Gross margin, FY2023: 7.65%Gross margin, FY2024: 7.64%Gross margin, FY2025: 7.52%Operating margin, FY2021: 0.99%Operating margin, FY2022: 0.92%Operating margin, FY2023: 1.30%Operating margin, FY2024: 1.24%Operating margin, FY2025: 1.05%Net margin, FY2021: 1.06%Net margin, FY2022: 0.98%Net margin, FY2023: 1.40%Net margin, FY2024: 1.31%Net margin, FY2025: 1.12%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 8.08%. Gross margin FY2022 7.54%. Gross margin FY2023 7.65%. Gross margin FY2024 7.64%. Gross margin FY2025 7.52%. Operating margin FY2021 0.99%. Operating margin FY2022 0.92%. Operating margin FY2023 1.30%. Operating margin FY2024 1.24%. Operating margin FY2025 1.05%. Net margin FY2021 1.06%. Net margin FY2022 0.98%. Net margin FY2023 1.40%. Net margin FY2024 1.31%. Net margin FY2025 1.12%.

Income trends

Revenue

1.55T JPY+2.30%

Operating income

16.32B JPY-13.18%

Net income

17.33B JPY-12.68%
Income trends across reported periods1.71T JPY1.09T JPY474.78B JPY−141.56B JPYRevenue, FY2021: 1.27T JPYRevenue, FY2022: 1.39T JPYRevenue, FY2023: 1.48T JPYRevenue, FY2024: 1.52T JPYRevenue, FY2025: 1.55T JPYOperating income, FY2021: 12.53B JPYOperating income, FY2022: 12.82B JPYOperating income, FY2023: 19.18B JPYOperating income, FY2024: 18.8B JPYOperating income, FY2025: 16.32B JPYNet income, FY2021: 13.38B JPYNet income, FY2022: 13.63B JPYNet income, FY2023: 20.66B JPYNet income, FY2024: 19.84B JPYNet income, FY2025: 17.33B JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 1.27T JPY. Revenue FY2022 1.39T JPY. Revenue FY2023 1.48T JPY. Revenue FY2024 1.52T JPY. Revenue FY2025 1.55T JPY. Operating income FY2021 12.53B JPY. Operating income FY2022 12.82B JPY. Operating income FY2023 19.18B JPY. Operating income FY2024 18.8B JPY. Operating income FY2025 16.32B JPY. Net income FY2021 13.38B JPY. Net income FY2022 13.63B JPY. Net income FY2023 20.66B JPY. Net income FY2024 19.84B JPY. Net income FY2025 17.33B JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue1.55T JPY1.52T JPY1.48T JPY1.39T JPY1.27T JPY
Cost of goods sold1.44T JPY1.4T JPY1.36T JPY1.28T JPY1.16T JPY
Gross profit116.75B JPY116B JPY112.99B JPY104.75B JPY102.28B JPY
Research and development—299M JPY445M JPY——
Selling, general, and administrative90.87B JPY87.9B JPY84.42B JPY83.53B JPY81.43B JPY
Operating expenses100.43B JPY97.2B JPY93.8B JPY91.94B JPY89.75B JPY
Interest income192M JPY93M JPY58M JPY58M JPY64M JPY
Interest expense56M JPY46M JPY145M JPY72M JPY76M JPY
Depreciation and amortization6.16B JPY6.08B JPY6.51B JPY6.41B JPY6.96B JPY
Operating income16.32B JPY18.8B JPY19.18B JPY12.82B JPY12.53B JPY
Net income17.33B JPY19.84B JPY20.66B JPY13.63B JPY13.38B JPY

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
45%
5 beats, 6 misses, 0 met estimates
Average EPS surprise
+27.31%
11 comparable reports
Latest EPS result
36.24
Estimate 45.48 · Miss by 20.32%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates161.39115.7670.1324.5Q1 '25MissQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26MissQ3 '26MissQ4 '26Estimate
Q1 2025, reported Feb 7, 2025: actual 75.92, estimate 77.36, surprise -1.86%, Miss. Q2 2025, reported May 14, 2025: actual 151.57, estimate 97.67, surprise +55.19%, Beat. Q3 2025, reported Aug 5, 2025: actual 53.61, estimate 28.82, surprise +86.02%, Beat. Q4 2025, reported Nov 12, 2025: actual 45.51, estimate 32.45, surprise +40.25%, Beat. Q1 2026, reported Feb 12, 2026: actual 127.93, estimate 114.42, surprise +11.81%, Beat. Q2 2026, reported May 13, 2026: actual 44.13, estimate 45.11, surprise -2.17%, Miss. Q3 2026, reported Aug 5, 2026: actual 36.24, estimate 45.48, surprise -20.32%, Miss. Q4 2026, reported Nov 6, 2026: actual —, estimate 43.15, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates441.5B407.49B373.47B339.46BQ1 '25BeatQ2 '25MissQ3 '25MissQ4 '25MissQ1 '26MissQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 7, 2025: actual 407.08B JPY, estimate 388.7B JPY, surprise +4.73%, Beat. Q2 2025, reported May 14, 2025: actual 356.44B JPY, estimate 359.34B JPY, surprise -0.81%, Miss. Q3 2025, reported Aug 5, 2025: actual 375.81B JPY, estimate 383.68B JPY, surprise -2.05%, Miss. Q4 2025, reported Nov 12, 2025: actual 392.09B JPY, estimate 392.26B JPY, surprise -0.04%, Miss. Q1 2026, reported Feb 12, 2026: actual 415.26B JPY, estimate 424.52B JPY, surprise -2.18%, Miss. Q2 2026, reported May 13, 2026: actual 370.21B JPY, estimate 363.47B JPY, surprise +1.85%, Beat. Q3 2026, reported Aug 5, 2026: actual 397.77B JPY, estimate 387.81B JPY, surprise +2.57%, Beat. Q4 2026, reported Nov 6, 2026: actual —, estimate 398.67B JPY, surprise —, Comparison unavailable.

8129.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥6,989

-0.31%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,817

+0.92%

HOYA Corporation logo

7741.T

HOYA Corporation

¥25,030

+0.54%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,280

+0.70%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,866.5

+1.16%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,405

+0.75%

ETFs holding 8129.T

Funds reporting this stock among their holdings, ordered by reported position size.

iShares Core TOPIX ETF logoiShares Core TOPIX ETF1475.T
Market value
609.2M
Weight
0.02%
AUM
2.89T JPY
Expense ratio
0.05%
Price / 1D
¥418.4+0.10%
Vanguard Total International Stock ETF logoVanguard Total International Stock ETFVXUS
Market value
19.88M
Weight
0.00%
AUM
646.2B USD
Expense ratio
0.05%
Price / 1D
$87.71+0.78%
Vanguard FTSE Developed Markets ETF logoVanguard FTSE Developed Markets ETFVEA
Market value
14.02M
Weight
0.00%
AUM
315B USD
Expense ratio
0.03%
Price / 1D
$73.42+0.80%
iShares Core MSCI EAFE ETF logoiShares Core MSCI EAFE ETFIEFA
Market value
13.78M
Weight
0.01%
AUM
195.14B USD
Expense ratio
0.07%
Price / 1D
$100.85+0.86%
Avantis International Small Cap Value ETF logoAvantis International Small Cap Value ETFAVDV
Market value
5.9M
Weight
0.03%
AUM
20.24B USD
Expense ratio
0.36%
Price / 1D
$111.95+1.06%
Vanguard FTSE All-World ex-US Small-Cap ETF logoVanguard FTSE All-World ex-US Small-Cap ETFVSS
Market value
5.36M
Weight
0.04%
AUM
13.6B USD
Expense ratio
0.06%
Price / 1D
$160.06+0.43%
iShares MSCI EAFE Small-Cap ETF logoiShares MSCI EAFE Small-Cap ETFSCZ
Market value
4.81M
Weight
0.04%
AUM
13.28B USD
Expense ratio
0.40%
Price / 1D
$86.60+0.70%
Schwab International Small-Cap Equity ETF logoSchwab International Small-Cap Equity ETFSCHC
Market value
3.01M
Weight
0.05%
AUM
5.73B USD
Expense ratio
0.06%
Price / 1D
$51.25+0.61%

Continue in GoAI

Research 8129.T

research.disclaimer